サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631253

腎機能検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Renal Function Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 206 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
腎機能検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月09日
発行: Fairfield Market Research
ページ情報: 英文 206 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の腎機能検査の市場規模は、2025年から2032年までのCAGRが7.10%と、大きな成長が見込まれています。同市場は、診断の進歩や腎臓の健康に対する意識の高まりによって、2025年の11億3,000万米ドルから2032年には18億3,000万米ドルに拡大すると予測されています。腎機能検査（RFT）は、血清クレアチニン、血中尿素窒素（BUN）、糸球体濾過量（GFR）などのパラメータを分析することにより、腎臓の健康状態を評価するために不可欠です。これらの検査は、慢性腎臓病（CKD）、腎不全、尿路感染症などの病態の診断に不可欠であり、タイムリーな介入と患者ケアの改善を可能にします。

慢性腎臓病の世界の有病率の増加と人口の高齢化が、腎臓診断薬に対する需要を牽引しています。自動化システムやハイスループット技術などの技術革新は、RFTの効率と精度を高めています。さらに、予防ヘルスケアや定期的な腎臓スクリーニングに対する意識の高まりが、市場の成長を後押ししています。機械としては、革新的なバイオマーカーの開発や、より迅速で利便性の高い診断を提供するポイントオブケア検査（POCT）ソリューションなどがあります。データ分析のための人工知能（AI）の統合は、正確な診断と個別化された治療計画を可能にすることで、市場をさらに牽引するものとみられています。

自動化されたハイスループット・システムは腎臓診断に革命をもたらし、血清クレアチニンやGFRのようなパラメータのより迅速で正確な分析を提供しています。こうした技術革新は患者のコンプライアンスを向上させ、市場の拡大を支えます。

人口の高齢化と生活習慣に関連する危険因子によってCKDの負担が増加しているため、正確な診断ツールの必要性が高まっています。腎機能検査はCKDの発見と管理に不可欠であり、世界の普及の原動力となっています。

当レポートでは、世界の腎機能検査市場について調査し、市場の概要とともに、製品タイプ別、検査タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の腎機能検査市場の見通し、2019年～2032年

  • 世界の腎機能検査市場の見通し、製品タイプ別、金額（10億米ドル）、2019年～2032年
  • 世界の腎機能検査市場の見通し、検査タイプ別、金額（10億米ドル）、2019年～2032年
  • 世界の腎機能検査市場の見通し、エンドユーザー別、金額（10億米ドル）、2019年～2032年
  • 世界の腎機能検査市場の見通し、地域別、金額（10億米ドル）、2019年～2032年

第4章 北米の腎機能検査市場の見通し、2019年～2032年

第5章 欧州の腎機能検査市場の見通し、2019年～2032年

第6章 アジア太平洋の腎機能検査市場の見通し、2019年～2032年

第7章 ラテンアメリカの腎機能検査市場の見通し、2019年～2032年

第8章 中東・アフリカの腎機能検査市場の見通し、2019年～2032年

第9章 競合情勢

  • 製品タイプ別と検査タイプ別のヒートマップ
  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers
    • Beckman Coulter (Danaher)
    • Abbott Laboratories Baxter International
    • Quest Diagnostic Incorporated
    • Sysmex Corporation
    • Laboratory Corporation of America Holdings (LabCorp
    • Randox Laboratories
    • ACON Laboratories
    • Arkray
    • Nova Biomedical
    • Idexx Laboratories
    • Elektronika
    • Cook Medical
    • VedaLab
    • Dx Gern Corp
    • Opti Medicals

第10章 付録

目次

The global Renal Function Test Market is expected to grow significantly, with a CAGR of 7.10% from 2025 to 2032. The market is projected to expand from US$ 1.13 billion in 2025 to US$ 1.83 billion by 2032, driven by advancements in diagnostics and rising awareness of kidney health. Renal function tests (RFTs) are essential for evaluating kidney health by analyzing parameters like serum creatinine, blood urea nitrogen (BUN), and glomerular filtration rate (GFR). These tests are critical for diagnosing conditions such as chronic kidney disease (CKD), renal failure, and urinary tract infections, enabling timely intervention and improved patient care.

The increasing global prevalence of chronic kidney diseases and an aging population are driving demand for renal diagnostics. Innovations such as automated systems and high-throughput technologies enhance the efficiency and precision of RFTs. Additionally, growing awareness about preventive healthcare and routine renal screening is fueling market growth. Opportunities include the development of innovative biomarkers and point-of-care testing (POCT) solutions, which offer faster and more convenient diagnostics. The integration of artificial intelligence (AI) for data analysis is set to further drive the market by enabling precise diagnostics and personalized treatment plans.

Market Growth Drivers

1.Advancements in Diagnostic Technologies

Automated and high-throughput systems have revolutionized renal diagnostics, offering faster, more accurate analysis of parameters like serum creatinine and GFR. These innovations improve patient compliance and support market expansion.

2.Rising Prevalence of Chronic Kidney Diseases (CKD)

The growing burden of CKD, fueled by an aging population and lifestyle-related risk factors, underscores the need for accurate diagnostic tools. Renal function tests are vital for detecting and managing CKD, driving global adoption.

3.Increased Focus on Preventive Healthcare

Rising awareness of the importance of regular screenings has led to higher demand for routine renal function testing, enabling early detection and intervention.

Market Restraints

1.Pricing Competition and Limited Innovation

Market concentration among major players creates pricing challenges for smaller companies and may hinder innovation, limiting the diversity of available solutions.

2.Regulatory Hurdles and Compliance Issues

Stringent regulatory requirements for medical diagnostics increase development costs and delay product approvals, complicating the timely introduction of new solutions.

Business Opportunities

1.Innovative Biomarkers and Diagnostic Tools

Research into novel biomarkers offers enhanced accuracy and specificity for renal function tests. Companies focusing on these innovations can differentiate their offerings and address rising demand for advanced diagnostics.

2.Expansion of Point-of-Care Testing (POCT)

POCT solutions provide rapid and convenient diagnostics, particularly for clinics and home care. Developing portable, user-friendly devices for renal assessments can capture a growing market segment.

3.Integration of Artificial Intelligence

AI-powered data analysis improves precision and enables personalized treatment plans, providing a competitive advantage for companies leveraging these technologies.

Regional Analysis

1.Europe

Europe leads the renal function test market due to its robust healthcare infrastructure and high prevalence of renal disorders. The region's emphasis on quality and preventive healthcare drives widespread adoption of advanced renal diagnostics, while stringent regulatory standards ensure product reliability.

2.South Asia and Pacific

The South Asia and Pacific region is the fastest-growing market, driven by rising CKD prevalence, improved healthcare infrastructure, and increasing awareness of early diagnosis.

3.North America

North America remains a key market, supported by advanced healthcare systems, technological innovations, and growing demand for preventive diagnostics.

4.Latin America, Middle East, and Africa

Emerging economies in these regions offer significant growth potential, driven by expanding healthcare infrastructure and increasing awareness of renal health.

Competitive Analysis

Key players in the Renal Function Test Market include:

  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers
  • Beckman Coulter (Danaher)
  • Abbott Laboratories
  • Quest Diagnostics Incorporated
  • Sysmex Corporation
  • LabCorp
  • Randox Laboratories
  • ACON Laboratories
  • Arkray
  • Nova Biomedical
  • Idexx Laboratories
  • Elektronika
  • Cook Medical
  • VedaLab
  • Dx Gern Corp
  • Opti Medicals

These companies prioritize innovation, strategic partnerships, and customer-focused solutions to maintain their competitive edge.

Renal Function Test Market Segmentation

1.By Product Type

  • Dipsticks
  • Disposable
  • Reagents

2.By Test Type

  • Urine Tests
  • Blood Tests

3.By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Laboratories and Institutes
  • Home Care Settings

4.By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Renal Function Test Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Renal Function Test Market Outlook, 2019 - 2032

  • 3.1. Global Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Dipsticks
      • 3.1.1.2. Disposable
      • 3.1.1.3. Reagents
  • 3.2. Global Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Urine
      • 3.2.1.2. Blood Test
  • 3.3. Global Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 3.3.1.2. Research Laboratories and Institutes
      • 3.3.1.3. Home Care Settings
  • 3.4. Global Renal Function Test Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Renal Function Test Market Outlook, 2019 - 2032

  • 4.1. North America Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Dipsticks
      • 4.1.1.2. Disposable
      • 4.1.1.3. Reagents
  • 4.2. North America Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Urine
      • 4.2.1.2. Blood Test
  • 4.3. North America Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 4.3.1.2. Research Laboratories and Institutes
      • 4.3.1.3. Home Care Settings
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. U.S. Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. U.S. Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Renal Function Test Market Outlook, 2019 - 2032

  • 5.1. Europe Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Dipsticks
      • 5.1.1.2. Disposable
      • 5.1.1.3. Reagents
  • 5.2. Europe Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Urine
      • 5.2.1.2. Blood Test
  • 5.3. Europe Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 5.3.1.2. Research Laboratories and Institutes
      • 5.3.1.3. Home Care Settings
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Renal Function Test Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Dipsticks
      • 6.1.1.2. Disposable
      • 6.1.1.3. Reagents
  • 6.2. Asia Pacific Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Urine
      • 6.2.1.2. Blood Test
  • 6.3. Asia Pacific Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 6.3.1.2. Research Laboratories and Institutes
      • 6.3.1.3. Home Care Settings
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Renal Function Test Market Outlook, 2019 - 2032

  • 7.1. Latin America Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Dipsticks
      • 7.1.1.2. Disposable
      • 7.1.1.3. Reagents
  • 7.2. Latin America Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Urine
      • 7.2.1.2. Blood Test
  • 7.3. Latin America Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 7.3.1.2. Research Laboratories and Institutes
      • 7.3.1.3. Home Care Settings
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Renal Function Test Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Dipsticks
      • 8.1.1.2. Disposable
      • 8.1.1.3. Reagents
  • 8.2. Middle East & Africa Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Urine
      • 8.2.1.2. Blood Test
  • 8.3. Middle East & Africa Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 8.3.1.2. Research Laboratories and Institutes
      • 8.3.1.3. Home Care Settings
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product Type vs by Test Type Heat map
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. F. Hoffmann-La Roche Ltd.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Siemens Healthineers
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Beckman Coulter (Danaher)
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Abbott Laboratories Baxter International
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Quest Diagnostic Incorporated
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Sysmex Corporation
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Laboratory Corporation of America Holdings (LabCorp
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Randox Laboratories
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. ACON Laboratories
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Arkray
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Nova Biomedical
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Idexx Laboratories
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Elektronika
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Cook Medical
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. VedaLab
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development
    • 9.4.16. Dx Gern Corp
      • 9.4.16.1. Company Overview
      • 9.4.16.2. Product Portfolio
      • 9.4.16.3. Financial Overview
      • 9.4.16.4. Business Strategies and Development
    • 9.4.17. Opti Medicals
      • 9.4.17.1. Company Overview
      • 9.4.17.2. Product Portfolio
      • 9.4.17.3. Financial Overview
      • 9.4.17.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations